Wednesday, July 8, 2026

pharma · Menopause · Vulvovaginal Atrophy · TXMD

TherapeuticsMD

TherapeuticsMD is a pharma organization headquartered in Boca Raton, USA. It trades on NYSE under ticker TXMD. Primary therapeutic focus areas include Menopause, Vulvovaginal Atrophy, Secondary Amenorrhea, Contraception,

Boca Raton, USA HQ
53 Employees
Public company Type
TXMD · NYSE Ticker
Company details
Status
Public
HQ
Boca Raton, USA
Employees
53
Programs
6
Drugs
6
Patents
0
Clinical program

Segesterone Acetate and Ethinyl Estradiol

Phase 1 · small molecule · Women

Segesterone Acetate and Ethinyl Estradiol for Women is a Phase 1 program (small_molecule) at TherapeuticsMD with 1 ClinicalTrials.gov record(s).

← All TherapeuticsMD projects Phase 1 small molecule completed

Internal code ANNOV3454-2 PMR

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
TherapeuticsMD
Phase
Phase 1
Modality
small_molecule
Indication
Women
Status
completed
Trials
1